Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karin Jordan

Showing results (21-30 of 105) with videos related to

Pageof 11
Sort By:
ESMO Open|August 20, 2019
How I treat cancer: treatment of rheumatological side effects of immunotherapyKarolina Benesova, Hanns-Martin Lorenz, Jan Leipe, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 24, 2025
Exploring antiemetic strategies in hematologic malignancies: a comprehensive literature review and evaluation of antiemetic efficacy in patients receiving high-dose chemotherapy prior to hematopoietic stem cell transplantationKarin Jordan, Berit Jordan, Jennifer Vanden Burgt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 26, 2005
Granisetron versus tropisetron for prophylaxis of acute chemotherapy-induced emesis: a pooled analysisKarin Jordan, Axel Hinke, Axel Grothey, et al.
Therapeutics and Clinical Risk Management|June 19, 2009
Anthracycline extravasation injuries: management with dexrazoxaneKarin Jordan, Timo Behlendorf, Franziska Mueller, et al.
Onkologie|January 22, 2005
Antiemetic efficacy of an oral suspension of granisetron plus dexamethasone and influence of quality of life on risk for nausea and vomitingKarin Jordan, Axel Grothey, Thomas Kegel, et al.
Clinical Colorectal Cancer|June 23, 2004
Phase II trial of capecitabine/irinotecan and capecitabine/oxaliplatin in advanced gastrointestinal cancersKarin Jordan, Olaf Kellner, Thomas Kegel, et al.
Breast Care (Basel, Switzerland)|November 19, 2014
Neuropharmacology and management of chemotherapy-induced nausea and vomiting in patients with breast cancerKarin Jordan, Judith Schaffrath, Franziska Jahn, et al.
Onkologie|August 1, 2012
Administration of chemotherapy by an arteriovenous fistula in a patient with metastatic rectal cancer after life-threatening, port thrombosis-associated cava superior syndrome. An option for patients without possibility of peripheral or central venous accessAlexander Stein, Sonja Hiemer, Karin Jordan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 2, 2017
Is the addition of a neurokinin-1 receptor antagonist beneficial in moderately emetogenic chemotherapy?-a systematic review and meta-analysisKarin Jordan, Luisa Blättermann, Axel Hinke, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 26, 2006
Atypical pulmonary embolism of port catheter fragments in oncology patientsAlexey Surov, Karin Jordan, Michael Buerke, et al.
Pageof 11

Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
ESMO Open|August 20, 2019
How I treat cancer: treatment of rheumatological side effects of immunotherapyKarolina Benesova, Hanns-Martin Lorenz, Jan Leipe, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 24, 2025
Exploring antiemetic strategies in hematologic malignancies: a comprehensive literature review and evaluation of antiemetic efficacy in patients receiving high-dose chemotherapy prior to hematopoietic stem cell transplantationKarin Jordan, Berit Jordan, Jennifer Vanden Burgt, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 26, 2005
Granisetron versus tropisetron for prophylaxis of acute chemotherapy-induced emesis: a pooled analysisKarin Jordan, Axel Hinke, Axel Grothey, et al.
Therapeutics and Clinical Risk Management|June 19, 2009
Anthracycline extravasation injuries: management with dexrazoxaneKarin Jordan, Timo Behlendorf, Franziska Mueller, et al.
Onkologie|January 22, 2005
Antiemetic efficacy of an oral suspension of granisetron plus dexamethasone and influence of quality of life on risk for nausea and vomitingKarin Jordan, Axel Grothey, Thomas Kegel, et al.
Clinical Colorectal Cancer|June 23, 2004
Phase II trial of capecitabine/irinotecan and capecitabine/oxaliplatin in advanced gastrointestinal cancersKarin Jordan, Olaf Kellner, Thomas Kegel, et al.
Breast Care (Basel, Switzerland)|November 19, 2014
Neuropharmacology and management of chemotherapy-induced nausea and vomiting in patients with breast cancerKarin Jordan, Judith Schaffrath, Franziska Jahn, et al.
Onkologie|August 1, 2012
Administration of chemotherapy by an arteriovenous fistula in a patient with metastatic rectal cancer after life-threatening, port thrombosis-associated cava superior syndrome. An option for patients without possibility of peripheral or central venous accessAlexander Stein, Sonja Hiemer, Karin Jordan, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 2, 2017
Is the addition of a neurokinin-1 receptor antagonist beneficial in moderately emetogenic chemotherapy?-a systematic review and meta-analysisKarin Jordan, Luisa Blättermann, Axel Hinke, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 26, 2006
Atypical pulmonary embolism of port catheter fragments in oncology patientsAlexey Surov, Karin Jordan, Michael Buerke, et al.
Pageof 11